BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322 [PMID: 35068871 DOI: 10.3748/wjg.v27.i48.8302]
URL: https://www.wjgnet.com/1948-5182/full/v27/i48/8302.htm
Number Citing Articles
1
Ziyu Liu, Yanan Li, Yufeng Wang, Xinquan Bai, Ying Zhang. Exosomes in HBV infectionClinica Chimica Acta 2023; 538: 65 doi: 10.1016/j.cca.2022.11.012
2
Yuan Fang, XiaoLi Zhang, HanFei Huang, Zhong Zeng. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little thingsJournal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04238-9
3
Lijuan Liu, Zhao Lv, Miao Wang, Dongyan Zhang, Dongying Liu, Fan Zhu. HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF SplicingInternational Journal of Molecular Sciences 2023; 24(4): 3263 doi: 10.3390/ijms24043263
4
Jin Wang, Yali Yang, Jingyi Lu, Xia Wang. The role of exosomes in therapeutic resistance of hepatocellular carcinomaHepatoma Research 2023;  doi: 10.20517/2394-5079.2023.85
5
Veronica Zelli, Chiara Compagnoni, Roberta Capelli, Alessandra Corrente, Mauro Di Vito Nolfi, Francesca Zazzeroni, Edoardo Alesse, Alessandra Tessitore. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.940056
6
Adane Adugna. Histomolecular characterisation of hepatitis B virus induced liver cancerReviews in Medical Virology 2023; 33(6) doi: 10.1002/rmv.2485
7
Li-Juan Liu, Zhao Lv, Xing Xue, Zhong-Yuan Xing, Fan Zhu. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting MitophagyCancers 2022; 14(23): 5781 doi: 10.3390/cancers14235781
8
Man Yao, Shufang Liang, Binbin Cheng. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicineFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1110922
9
Yingying Ding, Yong Zhang, Xuehong Liu. Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxiaFrontiers in Molecular Neuroscience 2022; 15 doi: 10.3389/fnmol.2022.1043947
10
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al-Hetty, Pushpamala Ramaiah, Alaa Hameed Fazaa, Abduladheem Turki Jalil, Fahad Alsaikhan, Jitendra Gupta, Andrés Alexis Ramírez-Coronel, Nahla A. Tayyib, Hu Peng. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpointEnvironmental Research 2023; 227: 115683 doi: 10.1016/j.envres.2023.115683
11
Ziyang Ye, Wenjie Chen, Genpeng Li, Jing Huang, Jianyong Lei. Tissue-derived extracellular vesicles in cancer progression: mechanisms, roles, and potential applicationsCancer and Metastasis Reviews 2023;  doi: 10.1007/s10555-023-10147-6
12
Ming-He Zhang, Yu-Feng Yuan, Li-Juan Liu, Yu-Xin Wei, Wan-Yue Yin, Lan-Zhuo-Yin Zheng, Ying-Ying Tang, Zhao Lv, Fan Zhu. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(31): 4706-4735 doi: 10.3748/wjg.v29.i31.4706